News

Back

Novasep Partners With Astrazeneca To Produce Covid-19 Oxford Vaccine For Europe

June 15th 2020

BioPark

Novasep announces that it has signed a partnership with the biopharmaceutical company AstraZeneca for the production of the Oxford University vaccine to prevent COVID-19 infection. 
This partnership follows the agreement between AstraZeneca and the Inclusive Alliance for Vaccines (IAV), whose members are France, Germany, Italy and the Netherlands, to supply the Oxford University's COVID-19 vaccine for the year 2021 for Europe. Please discover the press realse here.